Open Label Extension to Bridging Study CTBM100C2303

Clinical trial NCT00982930 · COMPLETED

Trial details

NCT number: NCT00982930
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pseudomonas Aeruginosa Cystic Fibrosis

Start date: 2009-08-12
Primary completion: 2011-10-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.